Browsing Tag
pathology test volume
1 post
Thyrocare (NSE: THYROCARE) declares 2:1 bonus, Rs 7 dividend—too good to ignore?
Thyrocare posts 82% profit growth in Q2 FY26, declares 2:1 bonus issue and ₹7 interim dividend. Read how franchise and pathology growth powered results.